Merck & Co has been accused of carrying out clinical trials of its Vioxx (rofecoxib) painkiller that were designed primarily for marketing purposes rather than to answer a clinical hypothesis.
NicOx and Merck have signed an agreement to collaborate on the
development of new antihypertensive drugs. The agreement follows
the successful completion of the companies' research collaboration,
which has generated promising...
Researchers at Merck Research Laboratories have discovered a
small-molecule drug that blocks the activity of FtsZ, an emerging
therapeutic target for antibacterial agents.